Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diuretics, Hypertension, and Arrhythmias Clinical Trial
NCT00000525Phase 3Completed
- Sponsor
- University of California, San Francisco
- Start
- Jul 1986
- Primary completion
- Sep 1989
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of hydrochlorothiazide in hypertension (HTN) (6 arms), sponsored by University of California, San Francisco. Primary endpoint: Ventricular arrhythmias on 24-hour Holter monitoring at 2 months. Started Jul 1986; status: completed.
02
Drugs
hydrochlorothiazide
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00000525.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000525.